CV Sciences ( OTCQB:CVSI ) on Thursday said it has entered into an agreement to acquire Extract Labs, a manufacturer and distributor of cannabinoid products including gummies, topicals and tinctures. The total consideration for the acquisition of Extract Labs payable at closing, consists.
Back to Health Page
